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Methicillin-resistant  Staphylococcus aureus (MRSA)
was cultured from the nose of a healthy dog whose owner
was colonized with MRSAwhile she worked in a Dutch nurs-
ing home. Pulsed-field gel electrophoresis and typing of the
staphylococcal chromosome cassette mec (SCCmec)
region showed that both MRSA strains were identical.  
The Case 
In 2000, a methicillin-resistant Staphylococcal aureus
(MRSA) strain was isolated from a patient admitted to a
multisite 1,100-bed tertiary-care teaching hospital in the
Netherlands. This strain recurred during several outbreaks
and spread to a 190-bed nursing home, which is part of the
hospital. During a large outbreak in 2003 in the nursing
home, 48 patients and 15 nurses were identified as carriers
of MRSA, either in their nares, throat, perineum, or a com-
bination of these sites. All MRSA isolates from the out-
breaks were sent to the National Institute of Public Health
and the Environment (RIVM) for identification and geno-
typing by pulsed-field gel electrophoresis (PFGE). Most
MRSA had the same PFGE pattern, RIVM cluster 35.
In 2003, a 31-year-old female nurse who had psoriasis
was identified as an MRSA carrier during the above-men-
tioned MRSAoutbreak. The nurse was treated to eliminate
MRSA carriage by applying mupirocin ointment in her
nares and washing with a chlorhexidine in ethanol solution
for 7 days. Initially she became MRSA-negative but later
converted to a carrier state again: samples from her nose,
throat, perineum, and skin lesions were taken, and MRSA
could be isolated from all sites. She was treated for her
psoriasis with topical application of triamcinolonace-
tonide/tetracycline to minimize the skin lesions and there-
after with oral doxycycline and rifampin to eliminate
MRSA. However, after some weeks, she became colonized
again at all previously mentioned sites. Screening her
home environment showed that her 1-year-old daughter,
who also had psoriasis, was colonized in the nose, throat,
and skin lesions. The nares, but not the perineum, of their
healthy pet dog were also colonized. The dog had not been
treated with antimicrobial drugs in the past. Samples from
nose, throat, and perineum from the patient’s husband were
MRSA negative, as were samples from nose, throat, per-
ineum, and skin lesions of the baby’s grandmother, who
also had psoriasis and took care of the baby when the
mother worked.
The staphylococci isolated from the nurse, her child,
and the dog were all identified as S. aureus by convention-
al methods, Vitek 2 (BioMérieux, Marcy-l’Etoile, France)
and Martineau polymerase chain reaction (PCR), which
targets the tuf gene (1). Susceptibility testing was per-
formed by using the Vitek 2, according to the manufactur-
er’s instructions. The isolates were resistant to penicillin G,
ofloxacin, trimethoprim-sulfamethoxazole, and fusidic
acid and tested susceptible to aminoglycosides, tetracy-
clines, erythromycin, clindamycin, vancomycin, rifampin,
and oxacillin. Disk diffusion testing demonstrated suscep-
tibility to mupirocin. Because the mecA-positive MRSA
isolates from previous outbreaks in the nursing home were
also resistant to ofloxacin, trimethoprim-sulfamethoxa-
zole, and fusidic acid, and tested either oxacillin resistant
or oxacillin susceptible by Vitek 2, the oxacillin resistance
of our isolates was also tested by several other methods.
The oxacillin screening test (Mueller-Hinton agar supple-
mented with 4% NaCl containing oxacillin at a concentra-
tion of 6 µg/mL) showed no growth after 24 h and 48 h of
incubation at 35°C. However, the Etest (AB Biodisk,
Solna, Sweden) showed that the isolates of the dog and the
baby had an oxacillin MIC of 6 mg/L and the isolate from
the nurse had an oxacillin MIC of 4 mg/L and could there-
fore be classified as oxacillin resistant. In addition, a PBP2
slide latex agglutination test (Oxoid, Haarlem,
Netherlands) was positive for all three isolates. The pres-
ence of the mecA gene (2) was demonstrated by a positive
mecA PCR for all three isolates.
Characterization of the staphylococcal chromosome
cassette  mec (SCCmec) was performed by typing the
ccrA/B gene complex, the mec complex, and by means of
a PCR strategy, which detects structural variants of
SCCmec covering the entire genetic element (2–6). Typing
the SCCmec of the MRSA strains cultured from the dog
and its owner showed that these seemed to be identical
(ccrA/B gene type 4, mec complex class B, and no loci A-
H were found). 
PFGE was carried out as described by Schwarzkopf et
al. (7). PFGE showed that all three MRSA isolates (from
the dog, the child, and the nurse) had indistinguishable
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demic human MRSAcluster. This cluster was the same one
cultured previously from patients and contacts in the nurs-
ing home during several outbreaks since 2000. On the basis
of these data, we assume that the dog became colonized
with the same strain as its owner through contact, and that
either the dog or the baby or an unknown source within the
nursing home reinfected the nurse. We finally treated moth-
er and child for the skin lesions simultaneously as men-
tioned before. Afterward, the mother and the dog received
an oral course of doxycycline and rifampin; the baby was
treated with clarithromycin and rifampin. This treatment
finally eliminated MRSA from the mother, the child, and
the dog. Topical application of antimicrobial drugs in dogs
is impractical. Follow-up cultures from the dog and the
child were taken for 2 months, the mother was monitored
for 9 months, and all cultures remained negative.
Conclusions
MRSAis an important cause of human nosocomial and
community-acquired infections worldwide. In contrast,
few cases of MRSA infections in dogs have been reported
(8–11). We report the first known case of human-to-animal
transmission of MRSA in the Netherlands. In the United
States, the transmission of MRSA between a pet dog and
its owners has been reported (12): a patient with diabetes
had recurrent infections of the leg with a mupirocin-resist-
ant MRSA strain, and his wife had cellulitis. Culture from
their dog’s nose grew an MRSA isolate with the same
antimicrobial-resistance pattern and an identical PFGE
pattern as the isolate cultured from wounds and nares of
the couple. Further recurrence of the MRSA infection of
the couple was only prevented when the dog was no longer
an MRSA carrier (12). Cefai et al. (13) isolated an MRSA
strain with an identical phage type from the nose of a male
nurse, his wife, and their pet dog. Transmission of MRSA
between humans and horses has also been suspected in a
veterinary teaching hospital in the United States (14). 
SCCmec is a mobile genetic element that carries the
mecA gene, which mediates methicillin resistance in
staphylococci. To date, four SCCmec types have been
described (2,3,6). Typing the SCCmec of the MRSAin our
study showed that they were of an uncommon type, which
could not be classified as one of the four SCCmec types.
Oliveira et al. (2) defined SCCmec type IV as harboring
ccrA/B type 4 in combination with characteristic loci,
whereas Ito et al. (3) defined SCCmec  type IV as the
unique combination of the class B mec and type 2 ccr gene
complex. Our MRSA had ccrA/B type 4 and class B mec
but no loci. Therefore, this MRSA cannot be classified in
the current system and may present a new SCCmec type.
This new type may spread successfully, as has been seen
with SCCmec types I–IV. During the 1960s, MRSA carry-
ing SCCmec type I spread across the world, followed by a
second wave of MRSA during the late 1970s that carried
SCCmec II; strains with SCCmec III spread during the
1980s, and strains with SCCmec type IV have been isolat-
ed worldwide since the beginning of the 1990s. Recently,
an isolate with a ccr5 type was described (15), which indi-
cates that additional SCCmec types are present in S.
aureus. Isolates with new SCCmec types may be the fron-
trunners of new waves of MRSA, posing an unknown
health threat.
Automated systems such as Vitek 2 are generally report-
ed to be reliable for testing methicillin or oxacillin suscep-
tibility, but the Vitek 2 did not detect MRSA in our study.
Misclassification of mecA-positive S. aureus as oxacillin
susceptible by the Vitek 2 has been reported before by
Felten et al. (16), especially in strains with relatively low
oxacillin MICs. The oxacillin-screening test also did not
detect our MRSAstrains. This can be explained by their rel-
atively low oxacillin MICs (4 mg/Land 6 mg/L, respective-
ly). The most reliable procedure for detecting MRSA
remainsthe PCR amplification of the mecA gene. MRSAin
this study was resistant to fluoroquinolones, which is com-
mon in MRSA but not in methicillin-susceptible S. aureus
(17). Therefore, fluoroquinolone-resistant S. aureus strains
should always be suspected of being MRSA and should be
tested for the presence of the mecA gene by PCR.
In conclusion, dogs and other pets living in close con-
tact with human MRSA carriers can become colonized
with MRSA. Failure to detect and treat these colonized
pets can result in recurrent MRSAcolonization or infection
in humans. Therefore, the risk of pets being the source of
unexplained carriage or relapse of infection in humans
should be recognized. Antimicrobial therapy of healthcare
workers and, at the same time, of MRSA carriers and any
infected family members or pets, can eliminate recurrent
MRSA carriage. Pets should be treated systemically, since
topical application is impractical.
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